"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Descriptor ID |
D023903
|
| MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
| Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial. Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1039-47.
-
Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol. 2012 Jun; 101(6):469-76.
-
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS). EuroIntervention. 2011 Oct 30; 7(6):670-9.
-
DES "club sandwich": a viable (if imperfect) option for recalcitrant restenosis. J Invasive Cardiol. 2011 Sep; 23(9):369-70.
-
Impact of the learning curve for endoscopic vein harvest on conduit quality and early graft patency. Ann Thorac Surg. 2011 May; 91(5):1385-91; discussion 1391-2.
-
Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010 Oct; 160(4):767-74.
-
Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. Circ J. 2010 Nov; 74(11):2334-9.
-
Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry). Am J Cardiol. 2010 Aug 01; 106(3):337-41.
-
Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol. 2010 May; 22(5):216-9.
-
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC Cardiovasc Interv. 2008 Oct; 1(5):524-32.